Get started
Author

Tim R. Wagner

Generation and Biological Evaluation of Fc Antigen Binding Fragment-Drug Conjugates as a Novel Antibody-Based Format for Targeted Drug Delivery
2021 · Sebastian Jäger, Tim R. Wagner, et al. · Bioconjugate Chemistry · 21
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
2022 · Niklas Kehl, Michael Kilian, et al. · Journal for ImmunoTherapy of Cancer · 12
PDF
Clinical decision support in hematological malignancies using a case-grounded AI agent
2026 · Julian Zoller, Michael Kalz, et al. · Nature Medicine · 3
PDF
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment
2026 · Niklas Kehl, Tim R. Wagner, et al. · Cancer Cell · 2
PDF
Conserved programs and specificities of T cells targeting hematological malignancies
2025 · Tim R. Wagner, Niklas Kehl, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PA-276 Latent Effector T Cells Mediate Immunotherapy Responses in the Bone Marrow Microenvironment
2026 · Niklas Kehl, Tim R. Wagner, et al. · Clinical Lymphoma Myeloma & Leukemia
PA-068 CD3-Engaging Bispecific Antibodies Convert Human Regulatory T Cells into Cytotoxic Effectors
2026 · Anna D. Metzler, Julius J. Michel, et al. · Clinical Lymphoma Myeloma & Leukemia
Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy
2025 · Julius Michel, Jan Frenking, et al. · Blood
PDF
Works count: 9
Citation count: 39
H-index: 3
I10-index: 2
Year
Topic
Type